GSK ANZ News and Activities
Presence
Headquarters: Australia
GSK is one of the...
- Forbes Global 2000 (#236);
- Fortune 500 Europe (#104);
- FTSE 350;
- Global Fortune 500 (#388);
- Stoxx 600;
- TOB Iconic 10,000.
GSK is a company listed under the stock ticker GSK (GB).
GSK has a direct presence in 21 countries.GSK has 25 subsidiaries including GSK ANZ, GSK APAC and GSK Austria.
Acquisition, funding and merger involving GSK.
- GSK has announced the acquisition of Rapt Therapeutics (posted on January 21 2026).
- IDRx and GSK have merged (posted on February 24 2025)..
- GSK has announced the acquisition of IDRx (posted on January 13 2025).
Executives
View the org chart displaying its 14 main executives
Most searched biographies at GSK ANZ
- Andrew Thomas, Vice President and General Manager, Australia
- Greg Madigan, Senior Finance Director
- Alex Dimitroff, Vice President, Business Unit Director, Vaccines
Popular executive movements at GSK
- Roanne Parry has joined the company as Chief People Officer (posted on May 4 2026).
- Diana Conrad, Chief People Officer, has left the company (posted on May 4 2026).
- Sally Jackson, Senior Vice President, Global Communications, has left the company (posted on April 7 2026).
Click here to view some more movements at GSK
Create your alert
to follow the executive moves at GSK ANZ.
Pharmaceuticals
GSK has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by GSK ANZ
Social media about GSK ANZ
- GSK ANZ on Wikipedia, Google News & Yahoo Finance
- GSK ANZ on LinkedIn, X (Twitter) & YouTube
